Diabetes

This hub delivers an in-depth, evidence-based exploration of diabetes mellitus, uniting authoritative articles on disease mechanisms, diagnosis, management, and prevention. Covering both type 1 and type 2 diabetes, as well as rare and secondary forms, this collection provides readers with comprehensive information on risk factors, clinical presentation, complications, and the latest advances in research and technology. Topics include the impact of nutrition and lifestyle, pharmacological and non-pharmacological therapies, monitoring strategies, acute and chronic complications, and innovative developments such as artificial pancreas systems and digital health tools. These resources also examine the psychosocial aspects of living with diabetes and offer practical guidance for both patients and healthcare professionals. Whether you seek foundational knowledge or current developments in diabetes care, this hub serves as a trusted, up-to-date reference.

Okra and Diabetes: What Research Says About Its Blood Sugar Control Effects

Emerging evidence from clinical and mechanistic studies reveals how okra’s natural compounds lower blood sugar, balance lipids, and support overall metabolic health in diabetes.

Risks to Infants of Diabetic Mothers

Diabetic Neuropathy Treatments

How does Gestational Diabetes Affect the Baby?

Is a Plant-Based Diet Good for Type 2 Diabetes?

Causes of Foot Pain

Diabetic Retinopathy Diagnosis

Diabetic Retinopathy Risk Factors

Diabetes Diagnosis

History of Diabetes

Diabetes Symptoms

Understanding MODY 5: A Rare Genetic Form of Diabetes

See more featured articles »

Walking After Meals: Small Habit, Big Metabolic Gains

Genetic Testing for Diabetes

Hypoglycemic Unawareness

Diabetes Risk Factors

Diabetic Ketoacidosis Causes

Advanced Diabetic Ketoacidosis

What is Diabetic Retinopathy?

What's Next for Semaglutide? Beyond Diabetes and Weight Loss

Diabetic Hypoglycemia Treatments

Pins and Needles and Diabetes

The Future of Diabetes Treatment

Research into a Cure for Diabetes

What is Diabetic Hypoglycemia?

The Risks of Prediabetes

Diabetic Coma Treatments

Adiponectin and Diabetes

The Impact of Glucagon on Diabetes Management

Navigating Insulin Pumps: Technology, Benefits, and What’s Next

Diabetic Mastopathy: Complication of Diabetes Mellitus

Diabetic Nephropathy Treatment

Bionic Advancements: The Next Generation of Insulin Delivery Devices

What is HbA1c?

Diabetic Emergencies: What to Do

Animals That Can Detect Hypoglycemia

How Baking Soda Affects People with Type 2 Diabetes

Does the 'Stomach Flu' Vaccine Prevent Type I Diabetes?

What Causes Diabetic Nephropathy (Kidney Disease)?

Diabetes and Mucormycosis

How Does Semaglutide Work to Lose Weight?

Diabetic Neuropathy Symptoms

Nonketotic Hyperosmolar Coma

Diabetes Complications

Diabetic Hypoglycemia Etiology

Diabetes and Pregnancy

Can I reverse my prediabetes naturally

Cause of Diabetic Coma

Diabetic Retinopathy Symptoms

Vitamin D and Type 2 Diabetes

What Causes Diabetes?

Harnessing the Power of AI: Predicting Diabetes Onset Before It Strikes

Semaglutide and Type 2 Diabetes: Efficacy, Safety, and Outcomes

Epigenetic Mechanisms in Type 2 Diabetes

Diabetes and Vision

What is Diabetes?

Low Sugar Foods for Diabetes

What is HbA1C Testing?

Diabetes Types

Treatment and Prognosis for Diabetic Mastopathy

Supplements for Diabetes

Are Low Carbohydrate Diets Good for Type 2 Diabetes?

Encapsulating Islet Cells for the Treatment of Diabetes

Diabetic Nephropathy Symptoms

Red Blood Cell Morphology Changes in Diabetes

Does the Keto Diet Increase the Risk of Diabetes?

Diabetes in Men versus Women

Diabetic Foot Problems

Diabetic Mastopathy Diagnosis

Diabetes Screening

What is a Diabetic Coma?

Diabetes Management

Diabetes and Wound Healing

Effects of Hyperglycemia on the Vascular System

What is Diabetic Nephropathy?

Alcohol and Diabetes

What are Nightmares and Why Do They Occur?

Diabetes and Skin Problems

Diabetic Retinopathy Treatments

Diabetic Neuropathy Pathogenesis

Diabetes and Periodontitis

Diabetes in Men

Artificial Pancreas Systems: The Future of Diabetes Management?

COVID-19 and Diabetes

Diabetic Neuropathy Diagnosis

What is Diabetic Neuropathy?

What is Diabetic Ketoacidosis?

Diabetic Coma Severe Hypoglycemia

Diabetes Pathophysiology

Diabetes and Sleep

Latest Diabetes News and Research

Endoscopic sleeve gastroplasty outperforms oral semaglutide in short-term weight loss

A comparative study, presented at ESGE Days 2026, has found that endoscopic sleeve gastroplasty (ESG) is associated with significantly greater short-term weight loss than oral semaglutide in adults with obesity.

15 May 2026

GLP-1 weight loss medications linked to significant drop in asthma flares

New research presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) shows the use of the new GLP-1 class of obesity drugs in people with asthma is associated with a 26 % fall in the number of asthma exacerbations and a 14% drop in use of asthma inhaler reliever use. The study is by Simon Høj and Dr Kjell Erik Julius Håkansson, Copenhagen University Hospital, Copenhagen, Denmark and colleagues.

15 May 2026

New research reassures mothers on NSAID safety during the first trimester

Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, taken during the first trimester of pregnancy are not associated with an increased risk of major birth defects, according to a new study published May 14th in the open-access journal PLOS Medicine by Sharon Daniel of Ben-Gurion University of the Negev and Clalit Health Services, Beer-Sheva, Israel, and colleagues.

15 May 2026

New obesity medications offer a potent tool for combating hypertension

A meta-analysis of 32 studies and 43,618 adults presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) shows that use of new classes of obesity drugs for weight loss is associated with a clinically relevant drop in blood pressure (BP): a 0.34 mmHg reduction in systolic BP per 1\% weight loss.

15 May 2026

Healthy plant-based foods may improve pregnancy cardiometabolic markers

Higher-quality plant-based diets were associated with more favorable cardiometabolic biomarkers in pregnant U.S. women, especially higher HDL-C and lower TG/HDL-C ratio. Indices that emphasized healthy plant foods, rather than simply penalizing animal foods, showed the strongest links with insulin resistance and lipid markers.

15 May 2026

The Goldilocks sleep zone: study links too little and too much sleep to biological aging

The Nature study introduces “Sleep Chart,” a framework linking self-reported sleep duration with 23 biological aging clocks derived from MRI, plasma proteomics, and metabolomics. Across UK Biobank participants, the lowest biological age gaps generally appeared between 6.4 and 7.8 hours of sleep, while shorter and longer sleep were associated with higher disease and mortality risk.

14 May 2026

Stanford scientists map the molecular diversity of different global populations

Researchers at the Stanford School of Medicine have found that ethnicity and geography may influence human molecular makeup - from metabolism and immunity to gut microbiota and biological aging.

14 May 2026

Study traces adult heart disease risk back to the womb

A child's future heart health may be partially shaped before they are born, reports a new Northwestern Medicine study that found pregnancy complications are linked to poorer cardiovascular health in offspring more than 20 years later.

14 May 2026

New research maps the biological toll of drinking

A new review published in the journal Addiction confirms drinking causes substantial harm to health. Some of those harms may be reversible if the person reduces or stops drinking.

14 May 2026

Smart technology meets wound care to combat dangerous diabetic ulcers

"Diabetic ulcers," which occur in patients with diabetes, are dangerous complications that can lead to amputation if the treatment window is missed. A joint research team has developed a "smart dressing patch" that can monitor wound conditions in real time.

14 May 2026

Study warns of rising cognitive impairment following a heart attack

The chance of developing cognitive impairment was significantly higher for people who have had a heart attack, according to a study published today in Stroke, the peer-reviewed scientific journal of the American Stroke Association, a division of the American Heart Association.

14 May 2026

Colbopasvir plus sofosbuvir achieves high cure rates in chronic hepatitis C

In this real‑world multicenter study (Wenzhou, China), 113 chronic hepatitis C patients received colbopasvir (60 mg) + sofosbuvir (400 mg) daily for 12 weeks. Overall SVR12 was 99.1% (112/113). SVR12 was 100% for genotypes 3a, 3b, 6a, and compensated cirrhosis, 93.3% for genotype 1b, and 90% for HBV co‑infection.

14 May 2026

Art history may help doctors better understand obesity stigma

Understanding how obesity has been portrayed in art across the ages can make doctors more empathic and less judgmental, which should lead to their patients achieving better outcomes, new reasearch at this year's European Congress on Obesity (ECO 2026) argues.

14 May 2026

Four OICR-funded studies explore transformative approaches in cancer care

Four new research studies funded by the Ontario Institute for Cancer Research (OICR) will deliver cutting-edge innovations by maximizing the impact of existing research and making the most out of patient contributions.

13 May 2026

Battery-free wearable sensor continuously monitors health through sweat

University of California, Irvine researchers have invented a wearable, wireless, battery-free, bioelectronic sensor to monitor users' health by analyzing molecular biomarkers in human sweat.

13 May 2026

Obesity drugs and surgery linked to greater fat-free mass loss

A new systematic review and meta-analysis of studies presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) shows that diet and exercise interventions result in a lower proportion of fat-free mass loss compared with obesity surgery or obesity drugs among people undergoing a weight loss of 10% or more.

13 May 2026

Semaglutide significantly reduces obesity in treatment-resistant young adults

A weekly dose of semaglutide (2.4 mg) leads to a clinically significant reduction in body mass index (BMI) and related health outcomes in young adults with severe obesity who are treatment resistant following hospital-based non-pharmacological obesity care during childhood, according to a randomized controlled trial being presented at this year's European Congress on Obesity (ECO) in Istanbul, Turkey (12-15 May).

13 May 2026